218Novel thromboelastography point-of-care test detects all commercially available DOACs at therapeutic concentrations and classifies them as direct thrombin or factor Xa inhibitors with high consistency. (28th August 2018) - Dias, J D; Lopez-Espina, C; Ippolito, J; Hsiao, H; Zaman, F; Mathew, B; Muresan, A; Walsh, M; Thurston, B; Artang, R; Bliden, K; Gurbel, P; et al.